Thus, CPT1AM-mediated increase in lipolysis, UCP1 protein expression and mitochondrial activity in brown adipocytes may lead to a new treatment of obesity and related disorders. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.